e-learning
resources
London 2016
Monday, 05.09.2016
Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?
Carsten Schwarz (Berlin, Germany), Carsten Schwarz, Horst Von Bernuth, Claudia Rolinck-Werninghaus, Jobst Fridolin Roehmel, Susanne Lau, Markus Becker, Maria Deja, Doris Staab
Source:
International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Session:
Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Session type:
Thematic Poster
Number:
2559
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Carsten Schwarz (Berlin, Germany), Carsten Schwarz, Horst Von Bernuth, Claudia Rolinck-Werninghaus, Jobst Fridolin Roehmel, Susanne Lau, Markus Becker, Maria Deja, Doris Staab. Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?. Eur Respir J 2016; 48: Suppl. 60, 2559
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Are epidemiological statistics on extrapulmonary tuberculosis correct?
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016
Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
International validation of FACED score in 672 patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016
Evaluation of fatigue state with virus-related novel biomarkers in obstructive lung diseases
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016
Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Clinical features of chronic obstructive pulmonary disease in never smokers
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Role of tuberculosis in COPD
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Assessment of patients preferences regarding characteristics associated with treatment of chronic obstructive pulmonary disease
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Characteristics of essential hypertension in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Risk of cardiovascular comorbidities in patients with idiopathic pulmonary fibrosis: Analysis of Medicare data
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Patients’ adherence to chronic treatment of pulmonary diseases
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Analysis of the microbiota of sputum samples from patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Bronchiectasis caused by pulmonary tuberculosis: The epidemiology, clinical presentations and the differences from non-tuberculosis-caused bronchiectasis
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Chronic obstructive pulmonary disease and comorbidities
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015
Current maintenance treatment of chronic obstructive pulmonary disease in China
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
Mortality after COPD-exacerbations: Learning from epidemiology
Source: International Congress 2014 – Clinical presentations
Year: 2014
Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept